Note 20 - Financial Information About the Parent, the Issuer and the Guarantors (Details) - Condensed Consolidating Statement of Cash Flows (USD $)
|
12 Months Ended |
Jun. 30, 2014
|
Jun. 30, 2013
|
Jun. 30, 2012
|
Condensed Cash Flow Statements, Captions [Line Items] |
|
|
|
Net cash provided by operating activities |
$ 59,889,000
|
$ 61,301,000
|
$ 37,701,000
|
Cash flows from investing activities: |
|
|
|
Capital expenditures |
(19,305,000)
|
(19,005,000)
|
(22,884,000)
|
Acquisitions |
|
(770,000)
|
(520,000)
|
Proceeds from the disposal of property, plant and equipment |
3,381,000
|
3,283,000
|
1,873,000
|
Change in restricted cash and investments |
6,926,000
|
(17,000)
|
975,000
|
Purchase of marketable securities |
(18,268,000)
|
(18,247,000)
|
(3,647,000)
|
Proceeds from the sale of marketable securities |
14,883,000
|
11,165,000
|
7,230,000
|
Other |
325,000
|
1,990,000
|
816,000
|
Net cash used in investing activities |
(12,058,000)
|
(21,601,000)
|
(16,157,000)
|
Cash flows from financing activities: |
|
|
|
Payments on long-term debt |
(480,000)
|
(26,104,000)
|
(12,204,000)
|
Purchases and other retirements of company stock |
|
|
(1,350,000)
|
Dividends paid |
(11,297,000)
|
(22,220,000)
|
(8,062,000)
|
Other |
525,000
|
1,758,000
|
738,000
|
Net cash used in financing activities |
(11,252,000)
|
(46,566,000)
|
(20,878,000)
|
Effect of exchange rate changes on cash |
(4,000)
|
(254,000)
|
536,000
|
Net increase (decrease) in cash and cash equivalents |
36,575,000
|
(7,120,000)
|
1,202,000
|
Cash & cash equivalents - beginning of year |
72,601,000
|
79,721,000
|
78,519,000
|
Cash & cash equivalents - end of year |
109,176,000
|
72,601,000
|
79,721,000
|
Parent Company [Member]
|
|
|
|
Condensed Cash Flow Statements, Captions [Line Items] |
|
|
|
Net cash provided by operating activities |
10,940,000
|
20,821,000
|
9,187,000
|
Cash flows from financing activities: |
|
|
|
Purchases and other retirements of company stock |
|
|
(1,350,000)
|
Dividends paid |
(11,297,000)
|
(22,220,000)
|
(8,062,000)
|
Other |
357,000
|
1,399,000
|
225,000
|
Net cash used in financing activities |
(10,940,000)
|
(20,821,000)
|
(9,187,000)
|
Subsidiary Issuer [Member]
|
|
|
|
Condensed Cash Flow Statements, Captions [Line Items] |
|
|
|
Net cash provided by operating activities |
34,812,000
|
24,720,000
|
3,939,000
|
Cash flows from investing activities: |
|
|
|
Capital expenditures |
(610,000)
|
(1,320,000)
|
(1,952,000)
|
Proceeds from the disposal of property, plant and equipment |
24,000
|
61,000
|
12,000
|
Change in restricted cash and investments |
6,926,000
|
(17,000)
|
975,000
|
Purchase of marketable securities |
(18,268,000)
|
(18,247,000)
|
(3,647,000)
|
Proceeds from the sale of marketable securities |
14,883,000
|
11,165,000
|
7,230,000
|
Other |
325,000
|
1,440,000
|
305,000
|
Net cash used in investing activities |
3,280,000
|
(6,918,000)
|
2,923,000
|
Cash flows from financing activities: |
|
|
|
Payments on long-term debt |
|
(25,800,000)
|
(11,917,000)
|
Other |
168,000
|
359,000
|
238,000
|
Net cash used in financing activities |
168,000
|
(25,441,000)
|
(11,679,000)
|
Net increase (decrease) in cash and cash equivalents |
38,260,000
|
(7,639,000)
|
(4,817,000)
|
Cash & cash equivalents - beginning of year |
57,307,000
|
64,946,000
|
69,763,000
|
Cash & cash equivalents - end of year |
95,567,000
|
57,307,000
|
64,946,000
|
Guarantor Subsidiaries [Member]
|
|
|
|
Condensed Cash Flow Statements, Captions [Line Items] |
|
|
|
Net cash provided by operating activities |
12,025,000
|
12,336,000
|
18,441,000
|
Cash flows from investing activities: |
|
|
|
Capital expenditures |
(17,018,000)
|
(14,847,000)
|
(15,721,000)
|
Acquisitions |
|
(770,000)
|
(520,000)
|
Proceeds from the disposal of property, plant and equipment |
3,357,000
|
3,222,000
|
1,861,000
|
Other |
|
550,000
|
511,000
|
Net cash used in investing activities |
(13,661,000)
|
(11,845,000)
|
(13,869,000)
|
Cash flows from financing activities: |
|
|
|
Payments on long-term debt |
(480,000)
|
(304,000)
|
(287,000)
|
Other |
|
|
275,000
|
Net cash used in financing activities |
(480,000)
|
(304,000)
|
(12,000)
|
Net increase (decrease) in cash and cash equivalents |
(2,116,000)
|
187,000
|
4,560,000
|
Cash & cash equivalents - beginning of year |
12,463,000
|
12,276,000
|
7,716,000
|
Cash & cash equivalents - end of year |
10,347,000
|
12,463,000
|
12,276,000
|
Non-Guarantor Subsidiaries [Member]
|
|
|
|
Condensed Cash Flow Statements, Captions [Line Items] |
|
|
|
Net cash provided by operating activities |
2,112,000
|
3,424,000
|
6,134,000
|
Cash flows from investing activities: |
|
|
|
Capital expenditures |
(1,677,000)
|
(2,838,000)
|
(5,211,000)
|
Net cash used in investing activities |
(1,677,000)
|
(2,838,000)
|
(5,211,000)
|
Cash flows from financing activities: |
|
|
|
Effect of exchange rate changes on cash |
(4,000)
|
(254,000)
|
536,000
|
Net increase (decrease) in cash and cash equivalents |
431,000
|
332,000
|
1,459,000
|
Cash & cash equivalents - beginning of year |
2,831,000
|
2,499,000
|
1,040,000
|
Cash & cash equivalents - end of year |
3,262,000
|
2,831,000
|
2,499,000
|
Consolidated Entities [Member]
|
|
|
|
Condensed Cash Flow Statements, Captions [Line Items] |
|
|
|
Net cash provided by operating activities |
59,889,000
|
61,301,000
|
37,701,000
|
Cash flows from investing activities: |
|
|
|
Capital expenditures |
(19,305,000)
|
(19,005,000)
|
(22,884,000)
|
Acquisitions |
|
(770,000)
|
(520,000)
|
Proceeds from the disposal of property, plant and equipment |
3,381,000
|
3,283,000
|
1,873,000
|
Change in restricted cash and investments |
6,926,000
|
(17,000)
|
975,000
|
Purchase of marketable securities |
(18,268,000)
|
(18,247,000)
|
(3,647,000)
|
Proceeds from the sale of marketable securities |
14,883,000
|
11,165,000
|
7,230,000
|
Other |
325,000
|
1,990,000
|
816,000
|
Net cash used in investing activities |
(12,058,000)
|
(21,601,000)
|
(16,157,000)
|
Cash flows from financing activities: |
|
|
|
Payments on long-term debt |
(480,000)
|
(26,104,000)
|
(12,204,000)
|
Purchases and other retirements of company stock |
|
|
(1,350,000)
|
Dividends paid |
(11,297,000)
|
(22,220,000)
|
(8,062,000)
|
Other |
525,000
|
1,758,000
|
738,000
|
Net cash used in financing activities |
(11,252,000)
|
(46,566,000)
|
(20,878,000)
|
Effect of exchange rate changes on cash |
(4,000)
|
(254,000)
|
536,000
|
Net increase (decrease) in cash and cash equivalents |
36,575,000
|
(7,120,000)
|
1,202,000
|
Cash & cash equivalents - beginning of year |
72,601,000
|
79,721,000
|
78,519,000
|
Cash & cash equivalents - end of year |
$ 109,176,000
|
$ 72,601,000
|
$ 79,721,000
|